NCT05267847

Brief Summary

The study is designed as a randomized controlled trial with two parallel groups. Children aged 5-9 years with primary molars from suffered symptomatic signs of irreversible pulpitis will be randomly assigned into two groups. The first group (experimental group) will be injected with 4% articaine 1:100.000 epinephrine (inferior alveolar nerve block). For the second group, the mandibular second primary molars will be anesthetized using 4% articaine 1:100.000 epinephrine using inferior alveolar nerve block.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
188

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 22, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

February 22, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 4, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2022

Completed
Last Updated

March 4, 2022

Status Verified

March 1, 2022

Enrollment Period

2 months

First QC Date

February 22, 2022

Last Update Submit

March 2, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain assessment

    Wong Backer pain scale

    up to 24 hours

Study Arms (2)

Cryotherapy during inferior alveolar nerve block

EXPERIMENTAL
Other: Cryotherapy

Inferior alveolar nerve block

ACTIVE COMPARATOR
Other: Traditional local anesthesia

Interventions

local anesthetic injection with articaine 4% 1:100,000 epinephrine then an application ice packs

Cryotherapy during inferior alveolar nerve block

local anesthetic injection with articaine 4% 1:100,000 epinephrine

Inferior alveolar nerve block

Eligibility Criteria

Age5 Years - 9 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Healthy children are classified as I or II according to ASA
  • Presence of at least one mandibular primary molar with symptomatic signs of irreversible pulpitis
  • Presence of at least two-thirds of the root length in periapical radiograph

You may not qualify if:

  • Unrestorable crowns
  • Children with systemic, severe behavior or emotional problems
  • Presence of gingival redness, swellings, fistulous of sinus tract
  • Radiographic evidence of internal root resorption, pulp stones or calcifications, and/or bone radiolucency

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Omar Ahmed

Al Minyā, 61111, Egypt

RECRUITING

Related Publications (1)

  • Elheeny AAH, Sermani DI, Saliab EA, Turky M. Cryotherapy and pain intensity during endodontic treatment of mandibular first permanent molars with symptomatic irreversible pulpitis: A randomized controlled trial. Clin Oral Investig. 2023 Aug;27(8):4585-4593. doi: 10.1007/s00784-023-05084-1. Epub 2023 Jun 3.

MeSH Terms

Conditions

Pain, Procedural

Interventions

Cryotherapy

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Therapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 22, 2022

First Posted

March 4, 2022

Study Start

February 22, 2022

Primary Completion

April 30, 2022

Study Completion

April 30, 2022

Last Updated

March 4, 2022

Record last verified: 2022-03

Locations